Invention Publication
- Patent Title: Recombinant Mycobacterium as an Immunotherapeutic Agent for the Second-Line Therapy of Bladder Carcinoma
-
Application No.: US18291147Application Date: 2022-07-20
-
Publication No.: US20240277825A1Publication Date: 2024-08-22
- Inventor: Leander GRODE
- Applicant: VAKZINE PROJEKT MANAGEMENT GMBH , SERUM INSTITUTE OF INDIA LTD.
- Applicant Address: DE Hannover
- Assignee: SERUM LIFE SCIENCE EUROPE GMBH,SERUM INSTITUTE OF INDIA LTD.
- Current Assignee: SERUM LIFE SCIENCE EUROPE GMBH,SERUM INSTITUTE OF INDIA LTD.
- Current Assignee Address: DE Hannover; IN Hadapsar Maharashtra
- Priority: EP 187253.6 2021.07.22
- International Application: PCT/EP2022/070373 2022.07.20
- Date entered country: 2024-01-22
- Main IPC: A61K39/04
- IPC: A61K39/04 ; A61K39/00 ; A61P35/00
Abstract:
The invention relates to a recombinant Mycobacterium cell for use as an immunotherapeutic agent in the treatment of bladder carcinoma, particularly in the second-line treatment of non-muscle-invasive bladder carcinoma.
Information query
